Suppr超能文献

筛选肺炎克雷伯菌分离株揭示了强生物膜形成菌和 1 类整合子的传播。

Screening of Klebsiella pneumoniae isolates reveals the spread of strong biofilm formers and class 1 integrons.

机构信息

Symbiosis School of Biological Sciences (SSBS), Symbiosis International (Deemed University) (SIU), Lavale, Pune, Maharashtra 412115, India.

L.N.C.T Medical College and Sewakunj Hospital, Kanadia Road, Indore, Madhya Pradesh 452016, India.

出版信息

J Appl Microbiol. 2024 Nov 4;135(11). doi: 10.1093/jambio/lxae275.

Abstract

AIMS

Klebsiella pneumoniae is a Gram-negative bacterium that can colonize, penetrate, and cause infections at several human anatomical locations. The emergence of hypervirulent K. pneumoniae and its ability to evade the immune system and develop antibiotic resistance has made it a key concern in the healthcare industry. The hypervirulent variants are increasingly involved in community-acquired infections. Therefore, it is pertinent to understand the biofilm formation potential among the clinical isolates.

METHODS AND RESULTS

We acquired 225 isolates of K. pneumoniae from the Department of Microbiology, Symbiosis University Hospital and Research Centre (SUHRC), Pune, India, over 1 year from March 2022 to March 2023, and evaluated antimicrobial susceptibility, hypermucoviscous phenotype, virulence, and antimicrobial-resistant gene distribution in K. pneumoniae isolates and established a correlation between antimicrobial resistance and integrons. Most isolates were strong biofilm formers (76%). The isolates harbored one or more carbapenemase/beta-lactamase-encoding gene combinations. Hypermucoviscous (HMKP) isolates had considerably greater positive rates for iutA, magA, K2 serotype, rmpA, and rmpA2 than non-HMKP isolates. Isolates carrying integrons (43%) showed significantly more antibiotic resistance.

CONCLUSION

The study reveals spread of strong biofilm formers with extensive virulence and antimicrobial-resistant genes, and integrons responsible for multidrug resistance among the clinical isolates of K. pneumoniae in Pune, India, posing a threat to the public health and necessitating close surveillance, accurate diagnosis, control, and therapeutic management of infections.

摘要

目的

肺炎克雷伯菌是一种革兰氏阴性细菌,能够在人体的多个解剖部位定植、穿透并引起感染。高毒力肺炎克雷伯菌的出现及其逃避免疫系统和产生抗生素耐药性的能力,使其成为医疗保健行业的一个关键关注点。高毒力变体越来越多地参与社区获得性感染。因此,了解临床分离株的生物膜形成潜力是很重要的。

方法和结果

我们从印度浦那的共生大学医院和研究中心(SUHRC)微生物学系获得了 225 株肺炎克雷伯菌,时间跨度为 2022 年 3 月至 2023 年 3 月的 1 年,评估了这些肺炎克雷伯菌分离株的抗菌药物敏感性、高黏液表型、毒力和抗菌药物耐药基因的分布,并建立了抗菌药物耐药性与整合子之间的相关性。大多数分离株是强生物膜形成者(76%)。这些分离株携带一种或多种碳青霉烯酶/β-内酰胺酶编码基因组合。高黏液性(HMKP)分离株的 iutA、magA、K2 血清型、rmpA 和 rmpA2 的阳性率明显高于非 HMKP 分离株。携带整合子的分离株(43%)显示出显著更高的抗生素耐药性。

结论

该研究揭示了在印度浦那的肺炎克雷伯菌临床分离株中,广泛传播的强生物膜形成者具有广泛的毒力和抗菌药物耐药基因,以及整合子导致的多药耐药性,这对公众健康构成了威胁,需要进行密切监测、准确诊断、控制和感染的治疗管理。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验